Dr. Hegde is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, 2014 - 2016
Harvard School of Public HealthMPH, 2016
University of Wisconsin Hospitals and ClinicsFellowship, Cardiovascular Disease, 2011 - 2014
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2007 - 2010
University of Kansas School of MedicineClass of 2007
Certifications & Licensure
MA State Medical License 2014 - 2025
WI State Medical License 2011 - 2015
MO State Medical License 2010 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 445 citationsMavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri
Lancet. 2020-09-12 - 67 citationsEffect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.Sheila M Hegde, Steven J Lester, Scott D Solomon, Michelle Michels, Perry M Elliott
Journal of the American College of Cardiology. 2021-12-21 - 41 citationsLeft ventricular ejection time is an independent predictor of incident heart failure in a community-based cohort.Tor Biering-Sørensen, Gabriela Querejeta Roca, Sheila M. Hegde, Amil M. Shah, Brian Claggett
European Journal of Heart Failure. 2018-07-01
Journal Articles
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-Risk Cardiovascular...Jacob A Udell, Sheila M Hegde, Deepak L Bhatt, J Michael Gaziano, Kristin Nichol, Matthew C Tattersall, Jonathan L Temte, Clyde Yancy, JAMA
- Sudden Death in Heart Failure with Preserved Ejection FractionScot D. Solomon, Sheila M. Hegde, Nancy K. Sweitzer, Sanjiv J. Shah, James C. Fang, Akshay S. Desai, ScienceDirect
Press Mentions
Mavacamten Improves Cardiac Structure, Function in Obstructive Hypertrophic CardiomyopathyDecember 29th, 2021- In Search of New Txs for Obstructive Hypertrophic CardiomyopathyDecember 15th, 2021
- Mavacamten Improves Pathophysiological Markers in Obstructive HCMDecember 13th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
